A new approach to gene therapy using Sleeping Beauty to genetically modify clinical‐grade T cells to target CD 19
Year: 2013
Type: review
Abstract: The advent of efficient approaches to the genetic modification of T cells has provided investigators with clinically appealing methods to improve the potency of tumor-specific clinical grade T cells. For example, gene therapy has been successfully used to enforce expression of chimeric antigen receptors (CARs) that provide T cells with ability to directly recognize tumor-associated antigens without the need for presentation by human leukocyte antigen. Gene transfer of CARs can be undertaken using viral-based and non-viral approaches. We have advanced DNA vectors derived from the Sleeping Beauty (SB) system to avoid the expense and manufacturing difficulty associated with transducing T cells with recombinant viral vectors. After electroporation, the transposon/transposase improves the efficiency of integration of plasmids used to express CAR and other transgenes in T cells. The SB system combined with artificial antigen-presenting cells (aAPC) can selectively propagate and thus retrieve CAR(+) T cells suitable for human application. This review describes the translation of the SB system and aAPC for use in clinical trials and highlights how a nimble and cost-effective approach to developing genetically modified T cells can be used to implement clinical trials infusing next-generation T cells with improved therapeutic potential.
Source: Immunological Reviews
DOI: 10.1111/imr.12137
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: National Cancer Institute
Awards: T-cell Therapy for B-lineage Acute Lymphoblastic Leukemia, Hematopoietic Cell Transplantation for Hematologic Malignancies, Enhancing the efficacy of CD19-specific cord blood-derived T Cells, Adoptive immunotherapy after umbilical cord blood transplant, IMAGING T CELLS BY POSITRON EMISSION TOMOGRAPHY, Cancer Center Support Grant
OpenAlex ID: W2093168673
